Analystreport

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. They now have a $35.0

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations